James M. Frincke serves as Executive at HOLLIS EDEN PHARMACEUTICALS INC /DE/, where they oversee executive responsibilities. Since joining the company, James M. Frincke has executed 8 insider transactions totaling $17.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 28, 2011 involved purchasing 25,000 shares valued at $4.0K.
James M. Frincke currently holds 994,672 shares of HOLLIS EDEN PHARMACEUTICALS INC /DE/ (HEPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James M. Frincke has been a net buyer of HEPH stock. They have purchased $11.3K and sold $6.4K worth of shares.
James M. Frincke's most recent insider trade was on Oct 28, 2011, when they purchased 25,000 shares at $0.16 per share.
Get notified when new Form 4 filings are submitted
| $0.16 |
| Discretionary |
| Oct 18, 2011 | HRBR | $3.3K | Purchase | 25,000 | $0.13 | Discretionary |
| Feb 13, 2007 | HEPH | $2.6K | Sale | 451 | $5.69 | Discretionary |
| Feb 13, 2007 | HEPH | $1.9K | Sale | 337 | $5.68 | Discretionary |
| Feb 13, 2007 | HEPH | $1.3K | Sale | 225 | $5.71 | Discretionary |
| Feb 13, 2007 | HEPH | $645 | Sale | 112 | $5.76 | Discretionary |
| Feb 13, 2006 | HEPH | $0 | Award | 9,000 | $N/A | Discretionary |